| Title |
Eculizumab in the management of paroxysmal nocturnal hemoglobinuria: patient selection and special considerations
|
|---|---|
| Published in |
Therapeutics and Clinical Risk Management, August 2016
|
| DOI | 10.2147/tcrm.s96720 |
| Pubmed ID | |
| Authors |
Fatimah Al-Ani, Ian Chin-Yee, Alejandro Lazo-Langner |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 3 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 2 | 67% |
| Members of the public | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 104 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Netherlands | 1 | <1% |
| Brunei Darussalam | 1 | <1% |
| Canada | 1 | <1% |
| Unknown | 101 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 20 | 19% |
| Researcher | 17 | 16% |
| Student > Master | 14 | 13% |
| Student > Bachelor | 12 | 12% |
| Student > Ph. D. Student | 7 | 7% |
| Other | 19 | 18% |
| Unknown | 15 | 14% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 36 | 35% |
| Biochemistry, Genetics and Molecular Biology | 12 | 12% |
| Pharmacology, Toxicology and Pharmaceutical Science | 10 | 10% |
| Nursing and Health Professions | 8 | 8% |
| Immunology and Microbiology | 6 | 6% |
| Other | 13 | 13% |
| Unknown | 19 | 18% |
Attention Score in Context
This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 August 2021.
All research outputs
#4,499,159
of 26,017,215 outputs
Outputs from Therapeutics and Clinical Risk Management
#216
of 1,331 outputs
Outputs of similar age
#76,641
of 387,966 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#2
of 45 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done well and is in the 81st percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,331 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.8. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 387,966 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 45 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.